Study shows combination stroke therapy safe and effective

University of Cincinnati-led trial successfully tests antiplatelet drug eptifibatide combined with tPA

2013-07-30

(Press-News.org) CINCINNATI -- The combination of the clot-busting drug tPA with an infusion of the antiplatelet drug eptifibatide dissolves blood clots safely and more quickly than tPA alone, a study led by University of Cincinnati (UC) researchers has found.

Results from the study, known as the CLEAR-ER Stroke Trial, are published online in the journal Stroke: Journal of the American Heart Association. UC was the coordinating center for the trial, which included nine medical centers comprising 21 hospitals.

Standard treatment for acute ischemic stroke (characterized by an obstruction to the blood flow, typically a clot), is intravenous (IV) delivery of U.S. Food and Drug Administration-approved tissue plasminogen activator (tPA) within three hours of stroke onset.

The CLEAR-ER (Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke – Enhanced Regimen) trial was a phase-2 clinical trial designed to determine the safety of an enhanced dosing regimen using eptifibatide and establish evidence for a phase-3 clinical trial, which would use a larger pool of subjects. As an antiplatelet medication, eptifibatide—delivered intravenously—works together with the tPA to break up the existing clot and prevents formation of additional clots by decreasing the clumping of blood platelets.

"Through our team's research efforts, we were able to determine that eptifibatide may be safely combined with medium-dose IV tPA administered within three hours of symptom onset and that a phase-3 clinical trial is warranted," says Opeolu Adeoye, MD, UC assistant professor of emergency medicine and neurosurgery and a neurointensivist at UC Medical Center.

Adeoye was co-principal investigator along with Arthur Pancioli, MD, professor and Richard C. Levy Chair for Emergency Medicine at UC. Both Adeoye and Pancioli are members of the UC Neuroscience Institute, one of four institutes affiliated with the UC College of Medicine and UC Health

Says Pancioli: "We know that the combination of these two medications dissolves clots faster and more completely than tPA alone. Our goal is to determine if we can use this combination to improve the outcomes for acute stroke victims."

CLEAR-ER investigators enrolled 126 subjects from July 2009 to October 2012. Of those, 101 received tPA plus eptifibatide and 25 received tPA alone. As the trial was a double-blind, randomized study, neither patient nor doctor was aware if the substance administered in addition to tPA was a medication or a placebo.

Investigators examined safety at specified endpoints, watching for incidence of intracerebral hemorrhage (ICH), and 90-day outcomes using a standardized measurement tool. Of the subjects who were given tPA plus eptifibatide, 50 (49.5 percent) had what were classified as good outcomes. Those who received tPA alone had nine good outcomes (36 percent).

Safety between the two groups was shown to be comparable at 36-hour, seven-day and 90-day endpoints.

The potential next step in investigation of the enhanced regimen, a phase-3 clinical trial, would typically use a larger pool of subjects determined by data from the phase-2 trial. Phase-3 trials, the last step before marketing of a medication, typically confirm its effectiveness, monitor side effects, compare it to commonly used treatments and collect information that will allow it to be used safely.

###

Adeoye also presented the study results at the American Heart Association/American Stroke Association's International Stroke Conference, held Feb. 5-8 in Honolulu.

The CLEAR-ER Stroke Trial was sponsored by the National Institutes of Health's National Institute of Neurological Disorders and Stroke (NINDS) as a Specialized Programs of Translational Research in Acute Stroke (SPOTRIAS) project.

Drugs for the CLEAR-ER trial were supplied by Genentech (tPA) and Merck (eptifibatide, marketed as Integrilin). Adeoye serves as a consultant to Genentech and is a member of its speakers' bureau. Pancioli reports no conflicts.

ELSE PRESS RELEASES FROM THIS DATE:

Breast reduction surgery found to improve physical, mental well-being

2013-07-30

Philadelphia, Pa. (July 30, 2013) – Breast reduction surgery produces measurable improvements in several important areas of health and quality of life, reports a study in the August issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS). The study used the BREAST-Q© questionnaire, a well-validated survey instrument, to document the physical and psychosocial health benefits of breast reduction surgery. "The improvement in physical well-being is important for justification of insurance coverage," according ...

Hardness, in depth

2013-07-30

WASHINGTON D.C. -- In today's precision manufacturing environment, designers of products as diverse as car airbag sensors, computer microchips, drill bits and paint often need to know the mechanical properties of their materials' down to the nanometer scale. Scientists have now built a machine that sets a new standard of accuracy for testing one of those properties: a material's hardness, which is a measure of its resistance to bumps and scratches. The new machine is called the Precision Nanoindentation Platform, or PNP. It was created in response to the need to test ...

Radio waves carry news of climate change

2013-07-30

The ionosphere, one of the regions of the upper atmosphere, plays an important role in global communications. Ionized by solar radiation, this electricity-rich region is used for the transmission of long wave communications, such as radio waves. Now Prof. Colin Price of Tel Aviv University's Department of Geophysical, Atmospheric and Planetary Sciences, working alongside PhD candidate Israel Silber, has discovered that the radio waves reflecting back to Earth from the ionosphere offer valuable news on climate change as well. Their research shows that the strength of ...

Fat digestibility in pigs study looks at oils in soybeans, corn co-products

2013-07-30

URBANA. Ill. – Pork producers need accurate information on the energy value of fat in feed ingredients to ensure that diets are formulated economically and in a way that maximizes pork fat quality. Researchers at the University of Illinois have determined the true ileal and total tract digestibility of fat in four corn co-products, as well as in full fat soybeans and corn oil. Hans H. Stein, a professor of animal sciences at U of I, led the team of researchers in the study in which they looked at four corn co-products: distillers dried grains with solubles (DDGS), high-protein ...

'Cowcatcher' enzyme fixes single-strand DNA

2013-07-30

Every time one of your cells divides, it exposes its most essential component to great danger: its genome, the sum total of all its genetic information, embodied in the double-stranded helix of DNA. Prior to cell division, this DNA splits into two single strands, each bearing sequences of biochemical bases that form templates for the genomes of the daughter cells. These single strands are particularly vulnerable to assaults by reactive oxygen species — toxic byproducts of respiration — that could cause changes in the genetic information they contain. Left unchecked, ...

How does hydrogen metallize?

2013-07-30

Washington, D.C.— Hydrogen is deceptively simple. It has only a single electron per atom, but it powers the sun and forms the majority of the observed universe. As such, it is naturally exposed to the entire range of pressures and temperatures available in the whole cosmos. But researchers are still struggling to understand even basic aspects of its various forms under high-pressure conditions. Experimental difficulties contribute to the lack of knowledge about hydrogen's forms. The containment of hydrogen at high pressures and the competition between its many similar ...

Aberrant splicing saps the strength of 'slow' muscle fibers

2013-07-30

HOUSTON (July 29, 3013) – When you sprint, the "fast" muscle fibers give you that winning kick. In a marathon or just day-to-day activity, however, the "slow," or type 1 fibers, keep you going for hours. In people with myotonic dystrophy, the second most common form of muscular dystrophy and the one most likely to occur in adults, these slow or type 1 fibers do not work well, wasting away as the genetic disorder takes its grim toll. In a report that appears online in the Proceedings of the National Academy of Sciences, Dr. Thomas A. Cooper, professor of pathology & immunology ...

Decision aids reduce men's conflict about PSA screening, but don't change their decisions

2013-07-30

WASHINGTON – Men who decide to be screened for prostate cancer and those who forgo PSA screening stick with their decisions after receiving materials explaining the risks and benefits of the test. The decision aids greatly increased their knowledge about screening and reduced their conflict about what to do, but did not have an impact on their screening decision when measured a year later. That's the finding of a new study published today in JAMA Internal Medicine that examined both web-based and printed tools aimed at helping men make informed decisions about PSA testing. In ...

Playing college football linked with high blood pressure risk

2013-07-30

College football players, especially linemen, may develop high blood pressure over the course of their first season, according to a small study in the American Heart Association's journal Circulation. Researchers documented higher blood pressure levels among 113 first-year college players. Only one player had already been diagnosed with hypertension before the season and 27 percent had a family history of hypertension. At post-season, researchers noted: 47 percent of players were considered pre-hypertensive, while 14 percent had stage 1 hypertension. While previous ...

Treatment for back pain varies despite published clinical guidelines

2013-07-30

Management of back pain appears to be variable, despite numerous published clinical guidelines, according to a report published by JAMA Internal Medicine, a JAMA Network publication. Spinal symptoms are among the most common reasons patients visit a physician and more than 10 percent of visits to primary care physicians relate to back and neck pain, the authors write in the study background. John N. Mafi, M.D., of Harvard Medical School, Boston, and colleagues used nationally representative data from the National Ambulatory Medical Care Survey and the National Hospital ...

LAST 30 PRESS RELEASES:

How rice plants tell head from toe during early growth

Scientists design solar-responsive biochar that accelerates environmental cleanup

Construction of a localized immune niche via supramolecular hydrogel vaccine to elicit durable and enhanced immunity against infectious diseases

Deep learning-based discovery of tetrahydrocarbazoles as broad-spectrum antitumor agents and click-activated strategy for targeted cancer therapy

DHL-11, a novel prieurianin-type limonoid isolated from Munronia henryi, targeting IMPDH2 to inhibit triple-negative breast cancer

Discovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model

Neg-entropy is the true drug target for chronic diseases

Oxygen-boosted dual-section microneedle patch for enhanced drug penetration and improved photodynamic and anti-inflammatory therapy in psoriasis

Around the world, children’s cooperative behaviors and norms converge toward community-specific norms in middle childhood, Boston College researchers report